MacLeod C L, Minning L, Gold D P, Terhorst C, Wilkinson M
Proc Natl Acad Sci U S A. 1986 Sep;83(18):6989-93. doi: 10.1073/pnas.83.18.6989.
The antigen-specific T-cell receptor (TCR) is composed of variable antigen-recognition chains TCR-alpha and TCR-beta in noncovalent association with the invariant T3 multimer. The TCR-alpha and TCR-beta chains are encoded by gene segments that must be juxtaposed by rearrangement in order to be expressed. To examine whether mechanisms other than gene rearrangement might regulate TCR/T3 gene expression, somatic cell hybrids were formed among closely related murine SL12 T-lymphoma clones that differ in TCR/T3 mRNA levels. In hybrid cells formed between cell clones in which one parent is TCR-beta+ and the other is TCR-beta-, the resultant hybrid cells lack detectable TCR-beta transcripts. Since the protein synthesis inhibitor cycloheximide partially reverses TCR-beta repression in the hybrid cells, we postulate that a labile repressor protein is involved. The amount of mRNA encoding one of the T3 polypeptide chains, T3-delta, is also strongly negatively transregulated in the same hybrid cells in which TCR-beta mRNA expression is repressed. The negative trans-regulation of TCR-beta and T3-delta mRNA expression is relatively specific, since the levels of TCR-alpha mRNA and several thymocyte surface antigens are not repressed in somatic cell hybrids. Our results indicate that rearrangement of the TCR genes alone is not sufficient for TCR-beta expression and that trans-acting factors regulate the amounts of both TCR-beta and T3-delta mRNA in this system.
抗原特异性T细胞受体(TCR)由可变的抗原识别链TCR-α和TCR-β组成,它们与恒定的T3多聚体非共价结合。TCR-α和TCR-β链由基因片段编码,这些基因片段必须通过重排并列在一起才能表达。为了研究除基因重排之外的机制是否可能调节TCR/T3基因表达,在TCR/T3 mRNA水平不同的密切相关的小鼠SL12 T淋巴瘤克隆之间形成了体细胞杂种。在一个亲本为TCR-β+而另一个亲本为TCR-β-的细胞克隆之间形成的杂种细胞中,所得杂种细胞缺乏可检测到的TCR-β转录本。由于蛋白质合成抑制剂环己酰亚胺可部分逆转杂种细胞中TCR-β的抑制作用,我们推测涉及一种不稳定的阻遏蛋白。在TCR-β mRNA表达受到抑制的同一杂种细胞中,编码T3多肽链之一T3-δ的mRNA量也受到强烈的负反式调节。TCR-β和T3-δ mRNA表达的负反式调节相对具有特异性,因为在体细胞杂种中TCR-α mRNA和几种胸腺细胞表面抗原的水平并未受到抑制。我们的结果表明,仅TCR基因的重排不足以实现TCR-β的表达,并且反式作用因子调节该系统中TCR-β和T3-δ mRNA的量。